Ethanol induces hydroxytyrosol formation in humans

Pharmacological Research

Volumn 95-96, Issue , 2015, Pages 27-33

  Pérez Mañá, Clara ^a,b   Farré, Magí ^a,b   Pujadas, Mitona ^a,c   Mustata, Cristina ^a   Menoyo, Esther ^a   Pastor, Antoni ^a,b,c   Langohr, Klaus ^a,d   De La Torre, Rafael ^a,c,e  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Alcohol; Dopamine; DOPET; Hydroxytyrosol; Tyrosol

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ALCOHOL; DOPAMINE; HOMOVANILLIC ACID; HYDROXYTYROSOL; PLACEBO; TYROSOL; 3,4-DIHYDROXYPHENYLETHANOL; ANTIOXIDANT; PHENETHYL ALCOHOL;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DOPAMINE METABOLISM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; URINARY EXCRETION; ANALOGS AND DERIVATIVES; BLOOD; BREATH ANALYSIS; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; METABOLISM; RANDOMIZED CONTROLLED TRIAL; URINE;

ADULT; ANTIOXIDANTS; BREATH TESTS; CROSS-OVER STUDIES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ETHANOL; HEALTHY VOLUNTEERS; HUMANS; MALE; PHENYLETHYL ALCOHOL;

EID: 84926165175     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.02.008     Document Type: Article

References (39)

1. A. Di Castelnuovo, S. Costanzo, V. Bagnardi, M.B. Donati, L. Iacoviello, and G. de Gaetano Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies Arch. Intern. Med. 166 2006 2437 2445
2. P.E. Ronksley, S.E. Brien, B.J. Turner, K.J. Mukamal, and W.A. Ghali Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis BMJ 342 2011 d671
3. A. Gea, M. Bes-Rastrollo, E. Toledo, M. Garcia-Lopez, J.J. Beunza, and R. Estruch Mediterranean alcohol-drinking pattern and mortality in the SUN (Seguimiento Universidad de Navarra) Project: a prospective cohort study Br. J. Nutr. 111 2014 1871 1880
4. K.J. Mukamal Understanding the mechanisms that link alcohol and lower risk of coronary heart disease Clin. Chem. 58 2012 664 666
5. J.B. Standridge, R.G. Zylstra, and S.M. Adams Alcohol consumption: an overview of benefits and risks South. Med. J. 97 2004 664 672
6. A.S. Hansen, P. Marckmann, L.O. Dragsted, I.L. Finné Nielsen, S.E. Nielsen, and M. Grønbaek Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease Eur. J. Clin. Nutr. 59 2005 449 455
7. E.B. Rimm, A. Klatsky, D. Grobbee, and M.J. Stampfer Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits BMJ 312 1996 731 736
8. G. Chiva-Blanch, S. Arranz, R.M. Lamuela-Raventos, and R. Estruch Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies Alcohol Alcohol. 48 2013 270 277
9. R. de la Torre, M.I. Covas, M.A. Pujadas, M. Fitó, and M. Farré Is dopamine behind the health benefits of red wine? Eur. J. Nutr. 45 2006 307 310
10. M.I. Covas, K. Nyyssönen, H.E. Poulsen, J. Kaikkonen, H.J. Zunft, and H. Kiesewetter The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial Ann. Intern. Med. 145 2006 333 341
11. EFSA Panel on Dietetic Products. Nutrition and allergies (NDA) Scientific opinion on the substantiation of health claims related to polyphenols in olive oil and protection of LDL particles from oxidative damage EFSA J. 9 2011 2033 Available from: http://www.efsa.europa.eu/en/efsajournal/doc/2033.pdf (accessed 30.11.14)
12. D. Auñon-Calles, E. Giordano, S. Bohnenberger, and F. Visioli Hydroxytyrosol is not genotoxic in vitro Pharmacol. Res. 74 2013 87 93
13. H. Schröder, R. de la Torre, R. Estruch, D. Corella, M.A. Martínez-González, J. Salas-Salvadó PREDIMED Study Investigators Alcohol consumption is associated with high concentrations of urinary hydroxytyrosol Am. J. Clin. Nutr. 90 2009 1329 1335
14. V.E. Davis, M.J. Walsh, and Y. Yamanaka Augmentation of alkaloid formation from dopamine by alcohol and acetaldehyde in vitro J. Pharmacol. Exp. Ther. 174 1970 401 412
15. V.E. Davis, and M.J. Walsh Alcohol, amines, and alkaloids: a possible biochemical basis for alcohol addiction Science 167 1970 1005 1007
16. A.W. Tank, and H. Weiner Ethanol-induced alteration of dopamine metabolism in rat liver Biochem. Pharmacol. 28 1979 3139 3147
17. C.L. Xu, and M.K. Sim Reduction of dihydroxyphenylacetic acid by a novel enzyme in the rat brain Biochem. Pharmacol. 50 1995 1333 1337
18. S.A. Marchitti, R.A. Deitrich, and V. Vasiliou Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase Pharmacol. Rev. 59 2007 125 150
19. V.E. Davis, H. Brown, J.A. Huff, and J.L. Cashaw The alteration of serotonin metabolism to 5-hydroxytryptophol by ethanol ingestion in man J. Lab. Clin. Med. 69 1967 132 140
20. L. Giovannini, M. Migliori, C. Filippi, N. Origlia, V. Panichi, M. Falchi, A.A. Bertelli, and A. Bertelli Inhibitory activity of the white wine compounds, tyrosol and caffeic acid, on lipopolysaccharide-induced tumor necrosis factor-alpha release in human peripheral blood mononuclear cells Int. J. Tissue React. 24 2002 53 56
21. M.I. Covas, E. Miró-Casas, M. Fitó, M. Farré-Albadalejo, E. Gimeno, J. Marrugat, and R. De La Torre Bioavailability of tyrosol, an antioxidant phenolic compound present in wine and olive oil, in humans Drugs Exp. Clin. Res. 29 2003 203 206
22. R. Di Benedetto, R. Varì, B. Scazzocchio, C. Filesi, C. Santangelo, C. Giovannini, P. Matarrese, M. D'Archivio, and R. Masella Tyrosol, the major extra virgin olive oil compound, restored intracellular antioxidant defences in spite of its weak antioxidative effectiveness Nutr. Metab. Cardiovasc. Dis. 17 7 2007 535 545
23. M. Tacker, P.J. Creaven, and W.M. McIsaac Alteration in tyramine metabolism by ethanol Biochem. Pharmacol. 19 1970 604 607
24. F. Modig, P.A. Fransson, M. Magnusson, and M. Patel Blood alcohol concentration at 0.06 and 0.10% causes a complex multifaceted deterioration of body movement control Alcohol 46 2012 75 88
25. O. Khymenets, M. Fitó, S. Touriño, D. Muñoz-Aguayo, M. Pujadas, and J.L. Torres Antioxidant activities of hydroxytyrosol main metabolites do not contribute to beneficial health effects after olive oil ingestion Drug Metab. Dispos. 38 2010 1417 1421
26. A. Kotronoulas, N. Pizarro, A. Serra, P. Robledo, J. Joglar, and L. Rubió Dose-dependent metabolic disposition of hydroxytyrosol and formation of mercapturates in rats Pharmacol. Res. 77 2013 47 56
27. E. Miró-Casas, M.I. Covas, M. Farre, M. Fito, J. Ortuño, and T. Weinbrenner Hydroxytyrosol disposition in humans Clin. Chem. 49 2003 945 952
28. E. Miró-Casas, M. Farré, M.I. Covas, J.O. Rodriguez, E. Menoyo, and R.M. Lamuela Capillary gas chromatography-mass spectrometry quantitative determination of hydroxytyrosol and tyrosol in human urine after olive oil intake Anal. Biochem. 294 2001 63 72
29. A. Poli, F. Marangoni, A. Avogaro, G. Barba, S. Bellentani, and M. Bucci Moderate alcohol use and health: a consensus document Nutr. Metab. Cardiovasc. Dis. 23 2013 487 504
30. L. Rubió, A. Serra, A. Macià, C. Piñol, M.P. Romero, and M.J. Motilva In vivo distribution and deconjugation of hydroxytyrosol phase II metabolites in red blood cells: a potential new target for hydroxytyrosol J. Funct. Foods 10 2014 139 143
31. R. de la Torre Bioavailability of olive oil phenolic compounds in humans Inflammopharmacology 16 2008 245 247
32. D. Wu, and A.I. Cederbaum Alcohol, oxidative stress, and free radical damage Alcohol Res. Health 27 2003 277 284
33. H. Schröder, J. Marrugat, M. Fitó, T. Weinbrenner, and M.I. Covas Alcohol consumption is directly associated with circulating oxidized low-density lipoprotein Free Radic. Biol. Med. 40 2006 1474 1481
34. P.H. van Golde, L.M. Sloots, W.P. Vermeulen, J.P. Wielders, H.C. Hart, and B.N. Bouma The role of alcohol in the anti low density lipoprotein oxidation activity of red wine Atherosclerosis 147 1999 365 370
35. S. Granados-Principal, J.L. Quiles, C.L. Ramirez-Tortosa, P. Sanchez-Rovira, and M.C. Ramirez-Tortosa Hydroxytyrosol: from laboratory investigations to future clinical trials Nutr. Rev. 68 2010 191 206
36. P.K. Wilkinson, A.J. Sedman, E. Sakmar, D.R. Kay, and J.G. Wagner Pharmacokinetics of ethanol after oral administration in the fasting state J. Pharmacokinet. Biopharm. 5 1977 207 224
37. N.H. Holford Clinical pharmacokinetics of ethanol Clin. Pharmacokinet. 13 1987 273 292
38. E. Baraona, C.S. Abittan, K. Dohmen, M. Moretti, G. Pozzato, and Z.W. Chayes Gender differences in pharmacokinetics of alcohol Alcohol. Clin. Exp. Res. 25 2001 502 507
39. M.S. Mumenthaler, J.L. Taylor, R. O'Hara, and J.A. Yesavage Gender differences in moderate drinking effects Alcohol Res. Health 23 1999 55 64